All stocks Β· BACPHAR
BP

Bacil Pharma Ltd.

BACPHAR BSE Drug Manufacturers - Specialty & Generic Healthcare

Bacil Pharma Limited develops, manufactures, and distributes pharmaceuticals products in India. The company offers tablets, capsules, injectables, ointments, and specialty products. Bacil Pharma Limited was incorporated…

ISIN INE711D01018
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Bacil Pharma Limited develops, manufactures, and distributes pharmaceuticals products in India. The company offers tablets, capsules, injectables, ointments, and specialty products. Bacil Pharma Limited was incorporated in 1987 and is based in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap22 Cr
P/E33.80
Div Yield0.00 %
Book Valueβ‚Ή17.30
52w Highβ‚Ή61.80
52w Lowβ‚Ή10.60
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.02 0.07 0.02 0.03 0.11 0.07 0.06 0.07 0.04 0.06 0.05 0.04 0.03
Operating Profit -0.02 -0.07 -0.02 -0.03 -0.11 -0.07 -0.06 -0.07 -0.04 -0.06 -0.05 -0.04 -0.03
Other Income 0.09 0.11 0.06 0.05 1.00 0.09 0.00 0.56 0.01 0.02 0.03 0.03 0.05
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.07 0.04 0.04 0.02 0.89 0.02 -0.06 0.49 -0.03 -0.04 -0.02 -0.01 0.02
Tax % 114.29 -1,450.00 0.00 0.00 24.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit -0.02 0.62 0.04 0.01 0.67 0.02 -0.06 0.48 -0.03 -0.04 -0.02 -0.01 0.02
EPS in Rs -0.01 0.43 0.03 0.01 0.47 0.01 -0.10 0.81 -0.05 -0.07 -0.03 -0.02 0.03

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 0.000.000.000.000.000.000.000.000.000.000.000.00
Expenses 0.250.250.190.170.160.160.180.260.290.170.130.11
Operating Profit -0.25-0.25-0.19-0.17-0.16-0.16-0.18-0.26-0.29-0.17-0.13-0.11
Other Income 1.240.660.130.07-3.70-0.07-0.12-0.07-3.420.170.060.08
Interest 0.000.000.000.000.000.000.010.000.030.000.000.00
Depreciation 0.000.000.000.000.000.000.010.010.010.000.000.00
Profit before tax 0.990.41-0.06-0.10-3.86-0.23-0.32-0.34-3.750.00-0.07-0.03
Tax % -57.580.000.000.000.000.000.000.000.00β€”0.000.00
Net Profit 1.560.40-0.06-0.10-3.86-0.24-0.32-0.34-3.750.00-0.07-0.03
EPS in Rs 1.090.28-0.10-0.17-6.55-0.41-0.54-0.58-6.370.00-0.12-0.05
Dividend Payout % 0.000.000.000.000.000.000.000.000.00β€”0.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 13.9713.976.536.536.536.536.536.536.536.536.536.53
Reserves 10.8411.46-5.31-5.43-5.30-5.14-5.14-4.62-4.29-0.09-0.13-0.06
Borrowings 0.000.160.100.020.030.180.170.100.000.310.270.14
Other Liabilities 2.580.020.010.010.012.522.552.552.510.020.020.02
Total Liabilities 27.3925.611.331.131.274.094.114.564.756.776.696.63
Fixed Assets 0.000.000.010.010.012.512.522.532.535.945.250.01
CWIP 0.000.000.000.000.000.000.000.000.000.000.005.88
Investments 24.2421.360.610.430.310.370.430.961.150.540.510.51
Other Assets 3.154.250.710.690.951.211.161.071.070.290.930.23
Total Assets 27.3925.611.331.131.274.094.114.564.756.776.696.63

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 0.710.400.00-0.15-4.01-0.40-0.38-0.301.440.000.060.26
Cash from Investing Activity -2.380.340.08-0.123.810.530.390.28-1.200.02-0.05-0.33
Cash from Financing Activity -0.622.08-0.060.060.33-0.07-0.06-0.160.000.000.000.00
Net Cash Flow -2.292.820.01-0.200.130.06-0.05-0.180.230.020.01-0.07
Free Cash Flow 0.710.400.00-0.15-4.01-0.40-0.38-0.301.140.00-3.210.24
CFO/OP % -284.00-160.000.0088.002,506.00250.00211.00115.00-497.000.00-46.00-236.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
ROCE % 3.93-0.97-13.11-12.61-7.07-5.75-2.80-8.47-6.01-1.49-1.05-0.45

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 0.00 0.00 0.08 0.08 0.20 0.20 10.60 20.71 42.67 42.67 42.67 42.67
Public 100.00 100.00 99.92 99.92 99.80 99.80 89.39 79.30 57.32 57.33 57.33 57.33
No. of Shareholders 7,326 7,226 7,431 7,431 7,532 7,638 7,461 6,902 6,794 6,770 6,628 6,647

Corporate Actions

11 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 20 Sep 2012 β€” β€” β€” General
Other 12 Sep 2011 β€” β€” β€” General
Other 09 Sep 2010 β€” β€” β€” General
Other 10 Sep 2009 β€” β€” β€” General
Other 11 Sep 2008 β€” β€” β€” General
Other 12 Sep 2007 β€” β€” β€” General
Other 13 Sep 2006 β€” β€” β€” General
Other 12 Sep 2005 β€” β€” β€” General
Other 10 Sep 2004 β€” β€” β€” General
Other 10 Sep 2003 β€” β€” β€” General
Other 04 Sep 2002 β€” β€” β€” General

Announcements

5 filings